Georgia has more than 400 life sciences companies, which include firms involved in biotechnology, pharmaceuticals, and medical devices.
In a new GHN Commentary, a state official says Georgia has a key asset in this field called a “value chain.”
That’s the idea “that a product can be born, researched, developed, clinically tried, manufactured and distributed locally, and at a much lower cost than other states can offer,’’ says E. Jane Caraway, of the Georgia Department of Economic Development.
One link in this chain is the Global Center for Medical Innovation in Atlanta, which has worked with more than 50 startups, clinician innovators and academic researchers to design, engineer, prototype, and facilitate commercialization of a range of innovative medical devices.